Clinical trial
Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular…
NCT00170742 · Novartis, Industry · Terminated
Key facts
| NCT number | NCT00170742 |
|---|---|
| Title | Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States. |
| Official title | A Randomized, Open Label, Controlled Study on the Efficacy and Safety of Octreotide i.m. in Patients With Proliferative Diabetic Retinopathy (PDR) After Start of Laser Coagulation |
| Lead sponsor | Novartis, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Proliferative Diabetic Retinopathy |
| Intervention type | Drug |
| Interventions | Octreotide, 30 mg i.m. LAR formulation |
| Enrollment | 17 |
| Start date | Dec 1, 2003 |
| Primary completion | May 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Aug 12, 2008 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: